The tariff classification of FreeFlow ankle-foot orthosis (AFO) from an undisclosed country
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Key passages, quoted from the ruling
- The applicable subheading for the FreeFlow AFO will 9021.10.0090, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “[o]rthopedic appliances …: [o]rthopedic or fracture appliances, and parts and accessories thereof: [o]ther.” The general rate of duty will be free.
Ruling text
In your letter dated July 11, 2025, you requested a tariff classification ruling on behalf of your client, Thorwear Inc. dba Elevate Movement. Additional information was received by email dated August 7, 2025. Samples were provided, examined and disposed of. Elevate FreeFlow Ankle-Foot Orthosis (AFO) is specially designed to help patients with drop foot and reduced dorsiflexion.
It consists of a footplate and lateral-posterior strut made from carbon fiber, a calf cuff, a CoolFlow liner fitting into the interior of the cuff, and a calf strap equipped with a BOA® Fit System for one-handed donning and doffing. You explain that the FreeFlow AFO supports the position of the foot and ankle for individuals unable to do so independently. This support restores proper gait mechanics, enhances mobility, and improves stability and balance, thereby reducing the risk of falls.
You state that by facilitating a more normal gait, supporting the lower limb, and helping maintain proper posture and alignment, the FreeFlow AFOs also minimize strain on muscles and joints - including the knees, hips, and back - which reduces pain and fatigue. The FreeFlow AFO is available in both right and left foot models and is fully adjustable. You claim that foot drop is a physical impairment and the FreeFlow AFO is specially designed as an ambulatory aid to assist individuals with foot drop.
Any other use is speculative and fugitive. The FreeFlow AFO’s carbon fiber footplate limits excessive downward movement of the forefoot (plantar flexion) while managing weight distribution and energy transfer during walking. A laterally positioned carbon fiber strut connects the footplate to the calf cuff, enhancing stability and preventing excessive inward (inversion) or outward (eversion) turning of the ankle.
The calf cuff and strap secures the AFO to the upper part of the lower leg, ensuring it fits properly to provide the prescribed sagittal-plane dorsiflexion support, while the CoolFlow liner enhances comfort to support extended wear. You explain that the design, materials, cost, and warranty of the FreeFlow AFO make it overwhelmingly more beneficial and probable for use by individuals with permanent or chronic foot drop, as opposed to those with acute or transient cases.
You state that Elevate is a recognized manufacturer of articles for the handicapped. Elevate’s marketing and sales channels are targeted to individuals suffering from foot drop and clinicians treating individuals with foot drop and Elevate works closely with healthcare providers and rehabilitation specialists to ensure that their products reach those who need them most. The FreeFlow AFO must be prescribed by a medical provider and are not available to the general public. They are covered by insurance.
The FreeFlow AFO IFU states that the product “is to be used exclusively for orthotic fittings of the foot and ankle” and “(t)his product must be prescribed and fitted by a certified healthcare professional.” Elevate is the importer of record and consignee for imports of these products and controls the distribution of them.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N351250).